[1]
Semenov, O. 2025. Assessment of cost aspects of prevention of excessive thromboformation in patients with COVID-19 in Ukraine. Social Pharmacy in Health Care. 11, 2 (Jul. 2025), 73–78. DOI:https://doi.org/10.24959/sphhcj.25./354.